News & Events

EOSAL, A NEW PROCEDURE FOR CNVs DETECTION. NEW ALTERNATIVE ANALYSIS METHOD VERSUS MLPA.

We developed EOSAL-CNV, a new method based on proportional amplification and labeling of amplicons in 1 PCR.


The EOSAL-CNV procedure allowed reliable CNV detection by a single PCR and fragment analysis in a capillary DNA sequencer. The results,  published in Clinical Chemistry,show that EOSAL-CNV represents an excellent alternative for CNV detection and characterization or validation in genetic studies and can be incorporated into routine CNV screening in genetic studies for detection and results verification. 
EOSAL was used for the following genes: BRCA1, BRCA2, CHEK2, MLH1, MSH6, MSH2, EPCAM and TP53 gene.









Seqplexing

Seqplexing

Biotechnology Company focused on the development of genetic tests applicable in clinical and research. Sequencing Multiplex S.L. aims to simplify the methodology of genetic studies with products with a high biotechnological component and high added value. Our solutions simplify procedures by reducing the total time to obtain results, handwork and rationalizing spending